Mustafa Ibrahim Abdelaziz Emara <br/><br/>
Stem cell therapy in multiple sclerosis /  
 استخدام الخلايا الجذعية لعلاج مرض التصلب المتناثر للجهاز العصبى 
Mustafa Ibrahim Abdelaziz Emara ; Supervised Manal Fahmy , Nermin Adel Kishk 
 - Cairo :   Mustafa Ibrahim Abdelaziz Emara ,   2014 
 - 184 P. :   facsimiles ;   25cm 
<br/><br/>Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Neuropsychiatry 
<br/><br/> HSCT and MSCT offer hope for a new effective treatment for MS. Recent trials of low intensity HSCT indicate that as researchers improve the conditioning protocol, they can significantlyreduce the adverse side effects without decreasing efficacy. Similarly, a recent clinical trial evaluating MSCT concluded it was a feasible and safe treatment method for MS patients. Given MSCTs positive potential on neural restoration and immunomodulation demonstrated in animal models, MSCT offers a low risk/high reward treatment option for MS patients. Additionally, HSCT and MSCT could work synergistically to further decrease adverse side effects and increase patient outcomes 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>HSCT Multiple sclerosis Stem cell therapy